1. Home
  2. WST vs BR Comparison

WST vs BR Comparison

Compare WST & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BR
  • Stock Information
  • Founded
  • WST 1923
  • BR 1962
  • Country
  • WST United States
  • BR United States
  • Employees
  • WST N/A
  • BR N/A
  • Industry
  • WST Medical/Dental Instruments
  • BR Business Services
  • Sector
  • WST Health Care
  • BR Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • BR Nasdaq
  • Market Cap
  • WST 15.6B
  • BR 28.2B
  • IPO Year
  • WST N/A
  • BR 2007
  • Fundamental
  • Price
  • WST $220.98
  • BR $233.76
  • Analyst Decision
  • WST Buy
  • BR Buy
  • Analyst Count
  • WST 7
  • BR 7
  • Target Price
  • WST $331.67
  • BR $250.83
  • AVG Volume (30 Days)
  • WST 615.3K
  • BR 466.5K
  • Earning Date
  • WST 07-24-2025
  • BR 08-05-2025
  • Dividend Yield
  • WST 0.38%
  • BR 1.50%
  • EPS Growth
  • WST N/A
  • BR 13.70
  • EPS
  • WST 6.37
  • BR 6.66
  • Revenue
  • WST $2,895,800,000.00
  • BR $6,768,000,000.00
  • Revenue This Year
  • WST $3.38
  • BR $8.99
  • Revenue Next Year
  • WST $5.82
  • BR $4.81
  • P/E Ratio
  • WST $34.74
  • BR $35.20
  • Revenue Growth
  • WST N/A
  • BR 5.72
  • 52 Week Low
  • WST $187.43
  • BR $200.63
  • 52 Week High
  • WST $352.33
  • BR $247.01
  • Technical
  • Relative Strength Index (RSI)
  • WST 49.84
  • BR 40.44
  • Support Level
  • WST $219.60
  • BR $232.56
  • Resistance Level
  • WST $233.84
  • BR $240.47
  • Average True Range (ATR)
  • WST 5.32
  • BR 4.51
  • MACD
  • WST 0.04
  • BR -0.72
  • Stochastic Oscillator
  • WST 29.22
  • BR 8.48

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BR Broadridge Financial Solutions Inc.

Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.

Share on Social Networks: